127 related articles for article (PubMed ID: 2538689)
1. Selective kappa antagonist properties of nor-binaltorphimine in the rat MES seizure model.
Tortella FC; Echevarria E; Lipkowski AW; Takemori AE; Portoghese PS; Holaday JW
Life Sci; 1989; 44(10):661-5. PubMed ID: 2538689
[TBL] [Abstract][Full Text] [Related]
2. Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats.
Przewłocka B; Lasoń W; Machelska H; van Luijtelaar G; Coenen A; Przewłocki R
Neurosci Lett; 1995 Feb; 186(2-3):131-4. PubMed ID: 7777181
[TBL] [Abstract][Full Text] [Related]
3. Nor-binaltorphimine decreases deprivation and opioid-induced feeding.
Levine AS; Grace M; Billington CJ; Portoghese PS
Brain Res; 1990 Nov; 534(1-2):60-4. PubMed ID: 1963567
[TBL] [Abstract][Full Text] [Related]
4. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.
Takemori AE; Ho BY; Naeseth JS; Portoghese PS
J Pharmacol Exp Ther; 1988 Jul; 246(1):255-8. PubMed ID: 2839664
[TBL] [Abstract][Full Text] [Related]
5. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
Devine DP; Leone P; Pocock D; Wise RA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
[TBL] [Abstract][Full Text] [Related]
6. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
7. U50,488, a highly selective kappa opioid: anticonvulsant profile in rats.
Tortella FC; Robles L; Holaday JW
J Pharmacol Exp Ther; 1986 Apr; 237(1):49-53. PubMed ID: 3007743
[TBL] [Abstract][Full Text] [Related]
8. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.
Takemori AE; Schwartz MM; Portoghese PS
J Pharmacol Exp Ther; 1988 Dec; 247(3):971-4. PubMed ID: 2849679
[TBL] [Abstract][Full Text] [Related]
9. The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats.
Jewett DC; Grace MK; Jones RM; Billington CJ; Portoghese PS; Levine AS
Brain Res; 2001 Aug; 909(1-2):75-80. PubMed ID: 11478923
[TBL] [Abstract][Full Text] [Related]
10. Differential antagonism of mu agonists by U50,488H in the rat.
Porreca F; Tortella FC
Life Sci; 1987 Dec; 41(23):2511-6. PubMed ID: 2824958
[TBL] [Abstract][Full Text] [Related]
11. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
Dosaka-Akita K; Tortella FC; Holaday JW; Long JB
J Pharmacol Exp Ther; 1993 Feb; 264(2):631-7. PubMed ID: 8382278
[TBL] [Abstract][Full Text] [Related]
12. Role of central mu, delta-1, and kappa-1 opioid receptors in opioid-induced muscle rigidity in the rat.
Vankova ME; Weinger MB; Chen DY; Bronson JB; Motis V; Koob GF
Anesthesiology; 1996 Sep; 85(3):574-83. PubMed ID: 8853088
[TBL] [Abstract][Full Text] [Related]
13. Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists.
Portoghese PS; Lipkowski AW; Takemori AE
Life Sci; 1987 Mar; 40(13):1287-92. PubMed ID: 2882399
[TBL] [Abstract][Full Text] [Related]
14. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs.
Werling LL; Frattali A; Portoghese PS; Takemori AE; Cox BM
J Pharmacol Exp Ther; 1988 Jul; 246(1):282-6. PubMed ID: 2839666
[TBL] [Abstract][Full Text] [Related]
15. Beta-funaltrexamine (beta-FNA) decreases deprivation and opioid-induced feeding.
Levine AS; Grace M; Billington CJ
Brain Res; 1991 Oct; 562(2):281-4. PubMed ID: 1663414
[TBL] [Abstract][Full Text] [Related]
16. Kappa-opioid receptor stimulation abolishes mu- but not delta-mediated inhibitory control of spinal Met-enkephalin release.
Collin E; Bourgoin S; Ferhat L; Hamon M; Cesselin F
Neurosci Lett; 1992 Jan; 134(2):238-42. PubMed ID: 1317026
[TBL] [Abstract][Full Text] [Related]
17. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
Vaupel DB; Cone EJ; Johnson RE; Su TP
J Pharmacol Exp Ther; 1990 Jan; 252(1):225-34. PubMed ID: 2153801
[TBL] [Abstract][Full Text] [Related]
18. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
Grider JR; Makhlouf GM
Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
[TBL] [Abstract][Full Text] [Related]
19. Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat.
Yuan CS
Eur J Pharmacol; 1996 Oct; 314(1-2):27-32. PubMed ID: 8957215
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
